Prinston Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PRINSTON INC, and what generic and branded alternatives to PRINSTON INC drugs are available?
PRINSTON INC has ninety approved drugs.
There are three tentative approvals on PRINSTON INC drugs.
Drugs and US Patents for Prinston Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prinston Inc | BENAZEPRIL HYDROCHLORIDE | benazepril hydrochloride | TABLET;ORAL | 076118-002 | Feb 11, 2004 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Prinston Inc | LOSARTAN POTASSIUM | losartan potassium | TABLET;ORAL | 091497-002 | Jun 6, 2011 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Prinston Inc | LISDEXAMFETAMINE DIMESYLATE | lisdexamfetamine dimesylate | CAPSULE;ORAL | 216266-006 | Aug 25, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Prinston Inc | FUROSEMIDE | furosemide | TABLET;ORAL | 076796-003 | Mar 26, 2004 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Prinston Inc | ROPINIROLE HYDROCHLORIDE | ropinirole hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 204413-002 | May 11, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Prinston Inc | DULOXETINE HYDROCHLORIDE | duloxetine hydrochloride | CAPSULE, DELAYED REL PELLETS;ORAL | 206653-003 | May 18, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Prinston Inc | SILODOSIN | silodosin | CAPSULE;ORAL | 209029-001 | Jan 4, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.